TABLE 1.
Condition | Exemplary clinical features | Exemplary laboratory features | Radiologic presentation | Histology |
CVID |
|
Hypogammaglobulinaemia |
|
|
LRBA/CTLA-4 deficiency |
|
|
See CVID | See CVID |
CGD |
|
Reduced “respiratory burst” |
|
|
STAT3 loss of function (AD HIES) |
|
|
|
|
STAT3 gain of function | Autoimmunopathies (cytopenias, lymphoproliferation, enteropathy, diabetes) |
|
|
|
MSMD |
|
Reduced IFN-γ production |
|
|
Blau syndrome/early onset sarcoidosis |
|
|
|
Non-necrotising granulomas |
NOD2-associated autoinflammatory disease |
|
|
|
Non-necrotising granulomas |
Chronic beryllium disease |
|
|
|
|
SAVI |
|
Constantly ↑ acute phase/inflammation parameters | Nodules Cavities Fixed infiltrates |
|
Granulomatosis with polyangiitis |
|
↑ Cytoplasmic ANCAs |
|
|
Eosinophilic granulomatosis with polyangiitis |
|
|
|
|
Hypersensitivity pneumonitis |
|
↑ Specific IgGs against organic compounds |
|
|
CVID: common variable immunodeficiency; GLILD: granulomatous-lymphocytic interstitial lung disease; GGO: ground-glass opacity; LRBA: lipopolysaccharide-responsive beige-like anchor protein; CTLA-4: cytotoxic T-lymphocyte-associated protein 4; CNS: central nervous system; CGD: chronic granulomatous disease; STAT-3: signal transducer and activator of transcription 3; Ig: immunoglobulin; AD: autosomal-dominant; HIES: hyper IgE syndrome; IL: interleukin; MSMD: Mendelian-susceptibility to mycobacterial disease; IFN: interferon; ACE: angiotensin-converting enzyme; BAL: bronchoalveolar lavage; NOD2: nucleotide-binding oligomerisation domain-containing protein 2; STING: stimulator of interferon genes; SAVI: STING-associated vasculopathy with onset in infancy; ANCA: anti-neutrophil cytoplasmic antibody.